Biogenic amines and polyamines in meat and meat products were determined
by HPLC. Spermine
and spermidine were the only amines always detected in meat and meat
products, ranging from
6.4 to 62.1 mg/kg for spermine and from 0.7 to 13.8 mg/kg for
spermidine. Tyramine, histamine,
putrescine, and cadaverine contents varied greatly, especially in
ripened products and even among
samples from the same commercial brand. Biogenic amines in cooked
products were, in general,
lower than 10 mg/kg, whereas 40% of ripened products reached levels
above 300 mg/kg. Amine
content in dry-cured ham was similar to those found in cooked products.
High amounts of biogenic
amines in some cooked products could be related to the use of low
hygienic quality meat. Besides
the contribution of the raw materials, amine formation can occur during
the fermentative-ripening
process. Adverse reactions due to interaction between monoamine
oxidase inhibitors drugs and
tyramine are expected in ripened products.
Keywords: Biogenic amines; meat; meat products; tyramine; histamine;
polyamines
Changes in 10 biogenic amines throughout tuna storage at 0, 8, and 20
°C were studied. ATP-related compounds, volatile amines, microbial counts, and organoleptic
assessment were also
monitored. No statistical differences were found for those
parameters between samples from different
anatomical areas. Similar evolution profiles were observed for
biogenic amines at the three
temperatures, although the highest amounts were achieved, in general,
in samples stored at 20 °C.
Histamine was the prevailing biogenic amine throughout storage,
and the defect action level of 50
μg/g was surpassed in samples stored at 8 or 20 °C before
organoleptic rejection. A great increase
in cadaverine and tyramine and a slight increase in putrescine were
also observed. Formation of
histamine, tyramine, and cadaverine seems to be related to mesophilic
flora, Enterobacteriaceae
and coliforms. Hygienic quality estimation by means of
trimethylamine values and IMP ratio yielded
inconsistent results in samples corresponding to the limit of
organoleptic acceptance. In accordance
with the results of this work, we proposed for tuna assessment the use
of an index calculated from
the sum of the contents of histamine, tyramine, cadaverine, and
putrescine which showed good
correlations with both time of storage and organoleptic
assessment.
Keywords: Biogenic amines; histamine; tuna spoilage; ATP-related compounds;
volatile amines
Agmatine and putrescine were always present in the 195 European beers
analyzed. Agmatine was
the prevailing amine (10.5 ± 5.8 mg/L), whereas putrescine levels
fluctuated slightly (4.8 ± 2.3
mg/L). Spermine, spermidine, tryptamine, and β-phenylethylamine
were not detected in every beer,
and their levels were <2 mg/L. Histamine, in general, ranged from
0.5 to 1.1 mg/L, although
relatively high levels were detected in some beers. Tyramine was
present in each beer, and together
with cadaverine, showed the highest fluctuations (non detected to 67.5
mg/L). Putrescine and
polyamines could be considered as “natural” constituents of beers,
whereas histamine, tyramine,
and cadaverine would be “indicators” of microbial contamination
during brewing. “Kriek” and
“spontaneous fermentation” beers showed the highest values of
tyramine and histamine. A
significant relationship was found between pH and tyramine, histamine,
and cadaverine in
“spontaneous fermentation” beers. Beers should be avoided by
patients receiving treatment with
monoamine oxidase inhibitors, because tyramine levels found in beers
were very variable and
unpredictable.
Keywords: Beers; biogenic amines; tyramine; histamine; alcoholic beverages;
polyamines
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.